Palisade Bio (PALI) Goodwill & Intangibles (2010 - 2021)
Palisade Bio (PALI) reported Goodwill & Intangibles of $141642.0 for Q1 2021, down 78.2% year-over-year from $649745.0 in Q1 2020, and down 3.73% on a QoQ basis from $147133.0 in Q4 2020.
Palisade Bio (PALI) has 12 years of Goodwill & Intangibles data on file, last reported at $141642.0 in Q1 2021.
- Quarterly Goodwill & Intangibles fell 78.2% year-over-year to $141642.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $141642.0 (down 78.2% YoY) and the FY2020 annual result came in at $147133.0, down 78.0% from the prior year.
- Goodwill & Intangibles declined to $141642.0 in Q1 2021 per PALI's latest filing, from $147133.0 in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $945066.0 in Q2 2017 and bottomed at $141642.0 in Q1 2021.
- The 5-year median for Goodwill & Intangibles is $738404.0 (2019), against an average of $669691.8.
- The widest annual swing landed in 2017, when Goodwill & Intangibles fell 6.98%; it then sank 78.2% in 2021.
- Tracing PALI's Goodwill & Intangibles over 5 years: stood at $883462.0 in 2017, then decreased by 13.57% to $763543.0 in 2018, then dropped by 12.39% to $668936.0 in 2019, then tumbled by 78.0% to $147133.0 in 2020, then dropped by 3.73% to $141642.0 in 2021.
- Per Business Quant, the three latest PALI Goodwill & Intangibles figures stand at $141642.0 (Q1 2021), $147133.0 (Q4 2020), and $152625.0 (Q3 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 141,642.00 |
| Dec 31, 2020 | 147,133.00 |
| Sep 30, 2020 | 152,625.00 |
| Jun 30, 2020 | 630,554.00 |
| Mar 31, 2020 | 649,745.00 |
| Dec 31, 2019 | 668,936.00 |
| Sep 30, 2019 | 688,127.00 |
| Jun 30, 2019 | 713,265.00 |
| Mar 31, 2019 | 738,404.00 |
| Dec 31, 2018 | 763,543.00 |
| Sep 30, 2018 | 788,733.00 |
| Jun 30, 2018 | 814,023.00 |
| Mar 31, 2018 | 839,314.00 |
| Dec 31, 2017 | 883,462.00 |
| Sep 30, 2017 | 915,457.00 |
| Jun 30, 2017 | 945,066.00 |
| Mar 31, 2017 | 904,732.00 |
| Dec 31, 2016 | 990,153.00 |
| Sep 30, 2016 | 984,125.00 |
| Jun 30, 2016 | 1.03 Mn |
| Mar 31, 2016 | 1.07 Mn |
| Dec 31, 2015 | 1.10 Mn |
| Sep 30, 2015 | 1.15 Mn |
| Jun 30, 2015 | 1.21 Mn |
| Mar 31, 2015 | 1.24 Mn |
| Dec 31, 2014 | 1.23 Mn |
| Sep 30, 2014 | 1.25 Mn |
| Jun 30, 2014 | 1.25 Mn |
| Mar 31, 2014 | 1.19 Mn |
| Dec 31, 2013 | 1.14 Mn |
| Sep 30, 2013 | 1.05 Mn |
| Jun 30, 2013 | 984,946.00 |
| Mar 31, 2013 | 876,781.00 |
| Dec 31, 2012 | 807,357.00 |
| Sep 30, 2012 | 772,186.00 |
| Jun 30, 2012 | 798,016.00 |
| Mar 31, 2012 | 721,452.00 |
| Dec 31, 2011 | 701,846.00 |
| Sep 30, 2011 | 658,411.00 |
| Jun 30, 2011 | 566,823.00 |
| Dec 31, 2010 | 500,154.00 |